[Early results obtained with the use of the xanthine oxidase inhibitor (4-hydroxypyrazol-pyrimidine) in gout. Preliminary note].
D057487:Enzyme Therapy; D006073:Gout / Q000188:drug therapy*; D006801:Humans; D014969:Xanthine Oxidase
D014969:Xanthine Oxidase
Primeros resultados obtenidos con el empleo del inhibidor de la xantina-oxidasa (HPP) en la gota. Nota previa.